Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03971474 |
|---|---|
| Brief Title: | Ramucirumab and Pembrolizumab Versus Standard of Care in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Non-Match Treatment Trial) |
| First Submitted : | May 29, 2019 |
| First Submitted that Met QC Criteria : | May 30, 2019 |
| First Posted : | June 3, 2019 |
| Last Update Submitted that Met QC Criteria : | August 11, 2020 |
| Last Update Posted : | August 12, 2020 |